LH Labcorp
NYSE · SEC CIK 920148 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $13.70M 20 sales by 10 insiders
- Filings on record
- 414 since 2021-08-03, latest 2026-09-03 08:21
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Schechter Adam H | Pres, CEO, Dir | — | $8.44M |
| Parham Richelle P | Dir | — | $1.78M |
| Wilkinson Peter J | SVP, CAO | — | $1.06M |
| ANDERSON KERRII B | Dir | — | $954.1K |
| Caveney Brian J | EVP, CMO, CSO, Pres of ED | — | $429.5K |
| Meltzer Jonathan C | EVP, Ops | — | $298.8K |
| Summy Amy B. | EVP, CMO | — | $283.4K |
| Kyle Kathryn W | EVP, CLO | — | $227.4K |
| van der Vaart Sandra D | EVP, Corp. Affairs | — | $156.0K |
| Vaughn Bryan T | EVP, Pres, Diagnostics | — | $67.0K |
Transactions 566
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-08-18 08:10 | 2026-08-17 | LH | ANDERSON KERRII B | Dir | S - Sale | $318.02 | -3,000 | 6,563 | -31% | -$954.1K |
| T | 2026-08-12 14:31 | 2026-08-11 | LH | Schechter Adam H | Pres, CEO, Dir | S - Sale | $320.37 | -4,669 | 102.6K | -4% | -$1.50M |
| 2026-08-06 08:26 | 2026-08-04 | LH | Summy Amy B. | EVP, CMO | S - Sale | $306.74 | -924 | 6,956 | -12% | -$283.4K | |
| DM | 2026-08-05 11:17 | 2026-08-03 | LH | Wilkinson Peter J | SVP, CAO | S - Sale+OE | $309.23 | -1,420 | 1,770 | -45% | -$439.1K |
| D | 2026-08-05 11:17 | 2026-08-03 | LH | Wilkinson Peter J | SVP, CAO | M - OptEx | $209.25 | +1,338 | 3,108 | +76% | +$280.0K |
| DT | 2026-07-06 09:37 | 2026-07-01 | LH | Kyle Kathryn W | EVP, CLO | M - OptEx | — | +256 | 4,069 | +7% | — |
| DT | 2026-07-06 09:37 | 2026-07-01 | LH | Kyle Kathryn W | EVP, CLO | F - Tax | $283.88 | -73 | 3,996 | -2% | -$20.7K |
| DT | 2026-07-06 09:37 | 2026-07-02 | LH | Kyle Kathryn W | EVP, CLO | S - Sale+OE | $286.19 | -92 | 3,904 | -2% | -$26.3K |
| DT | 2026-07-06 09:36 | 2026-07-01 | LH | Vaughn Bryan T | EVP, Pres, Diagnostics | M - OptEx | — | +327 | 7,073 | +5% | — |
| DT | 2026-07-06 09:36 | 2026-07-01 | LH | Vaughn Bryan T | EVP, Pres, Diagnostics | F - Tax | $283.88 | -93 | 6,980 | -1% | -$26.4K |
| DT | 2026-07-06 09:36 | 2026-07-02 | LH | Vaughn Bryan T | EVP, Pres, Diagnostics | S - Sale+OE | $286.19 | -234 | 6,746 | -3% | -$67.0K |
| T | 2026-06-10 09:01 | 2026-06-08 | LH | Kyle Kathryn W | EVP, CLO | S - Sale | $263.89 | -762 | 3,813 | -17% | -$201.1K |
| T | 2026-05-13 09:30 | 2026-05-11 | LH | Schechter Adam H | Pres, CEO, Dir | S - Sale | $254.50 | -5,903 | 107.2K | -5% | -$1.50M |
| 2026-03-30 | 2026-03-26 | LH | Vaughn Bryan T | EVP, Diagnostics | A - Grant | $0.00 | +1,584 | 7,197 | +28% | $0 | |
| 2026-03-30 | 2026-03-26 | LH | Vaughn Bryan T | EVP, Diagnostics | F - Tax | $268.38 | -451 | 6,746 | -6% | -$121.0K | |
| 2026-03-30 | 2026-03-26 | LH | van der Vaart Sandra D | EVP, Corp. Affairs | A - Grant | $0.00 | +6,382 | 8,961 | +247% | $0 | |
| 2026-03-30 | 2026-03-26 | LH | van der Vaart Sandra D | EVP, Corp. Affairs | F - Tax | $268.38 | -2,722 | 6,239 | -30% | -$730.5K | |
| M | 2026-03-30 | 2026-03-26 | LH | Schroeder Mark S | EVP, COO, Pres Diagnostics | F - Tax | $268.38 | -6,068 | 11.2K | -35% | -$1.63M |
| M | 2026-03-30 | 2026-03-26 | LH | Schroeder Mark S | EVP, COO, Pres Diagnostics | A - Grant | $0.00 | +12.3K | 15.8K | +350% | $0 |
| 2026-03-30 | 2026-03-26 | LH | Summy Amy B. | EVP, CMO | A - Grant | $0.00 | +3,994 | 9,716 | +70% | $0 | |
| 2026-03-30 | 2026-03-26 | LH | Summy Amy B. | EVP, CMO | F - Tax | $268.38 | -1,836 | 7,880 | -19% | -$492.7K | |
| 2026-03-30 | 2026-03-26 | LH | Bailey Megan D. | EVP, Pres, Central Labs, Intl | F - Tax | $268.38 | -481 | 4,851 | -9% | -$129.1K | |
| 2026-03-30 | 2026-03-26 | LH | Bailey Megan D. | EVP, Pres, Central Labs, Intl | A - Grant | $0.00 | +1,184 | 5,332 | +29% | $0 | |
| 2026-03-30 | 2026-03-26 | LH | GRAHAM ANITA Z | EVP, CHRO | A - Grant | $0.00 | +6,604 | 8,064 | +452% | $0 | |
| 2026-03-30 | 2026-03-26 | LH | GRAHAM ANITA Z | EVP, CHRO | F - Tax | $268.38 | -2,879 | 5,185 | -36% | -$772.7K | |
| M | 2026-03-30 | 2026-03-26 | LH | Caveney Brian J | EVP, CMO, CSO, Pres of ED | A - Grant | $0.00 | +11.3K | 37.4K | +43% | $0 |
| M | 2026-03-30 | 2026-03-26 | LH | Caveney Brian J | EVP, CMO, CSO, Pres of ED | F - Tax | $268.38 | -4,905 | 36.5K | -12% | -$1.32M |
| 2026-03-30 | 2026-03-26 | LH | Kyle Kathryn W | EVP, CLO | A - Grant | $0.00 | +1,584 | 5,026 | +46% | $0 | |
| 2026-03-30 | 2026-03-26 | LH | Kyle Kathryn W | EVP, CLO | F - Tax | $268.38 | -451 | 4,575 | -9% | -$121.0K | |
| 2026-03-30 | 2026-03-26 | LH | Oyegunwa Akinbolade | EVP, CIO, CTO | A - Grant | $0.00 | +1,340 | 5,446 | +33% | $0 | |
| 2026-03-30 | 2026-03-26 | LH | Oyegunwa Akinbolade | EVP, CIO, CTO | F - Tax | $268.38 | -382 | 5,064 | -7% | -$102.5K | |
| 2026-03-30 | 2026-03-26 | LH | Wilkinson Peter J | SVP, CAO | F - Tax | $268.38 | -755 | 3,485 | -18% | -$202.6K | |
| 2026-03-30 | 2026-03-27 | LH | Wilkinson Peter J | SVP, CAO | S - Sale | $267.05 | -1,633 | 1,852 | -47% | -$436.1K | |
| 2026-03-30 | 2026-03-26 | LH | Wilkinson Peter J | SVP, CAO | A - Grant | $0.00 | +2,388 | 4,240 | +129% | $0 | |
| 2026-03-30 | 2026-03-26 | LH | Meltzer Jonathan C | EVP, Ops | A - Grant | $0.00 | +2,388 | 5,170 | +86% | $0 | |
| 2026-03-30 | 2026-03-26 | LH | Meltzer Jonathan C | EVP, Ops | F - Tax | $268.38 | -711 | 4,459 | -14% | -$190.8K | |
| 2026-03-30 | 2026-03-27 | LH | Meltzer Jonathan C | EVP, Ops | S - Sale | $267.05 | -839 | 3,620 | -19% | -$224.1K | |
| 2026-03-30 | 2026-03-26 | LH | Schechter Adam H | Pres, CEO, Dir | F - Tax | $268.38 | -26.1K | 113.1K | -19% | -$7.01M | |
| 2026-03-30 | 2026-03-26 | LH | Schechter Adam H | Pres, CEO, Dir | A - Grant | $0.00 | +58.5K | 139.2K | +72% | $0 | |
| 2026-03-05 | 2026-03-03 | LH | Schechter Adam H | Pres, CEO, Dir | S - Sale | $279.96 | -8,705 | 80.8K | -10% | -$2.44M | |
| 2026-03-03 | 2026-02-27 | LH | van der Vaart Sandra D | EVP, Corp. Affairs | S - Sale | $284.91 | -547.54 | 2,579 | -18% | -$156.0K | |
| 2026-02-26 | 2026-02-24 | LH | Caveney Brian J | EVP, CMO, CSO, Pres of ED | S - Sale | $286.31 | -1,500 | 30.1K | -5% | -$429.5K | |
| 2026-02-23 | 2026-02-19 | LH | Wilkinson Peter J | SVP, CAO | S - Sale | $277.94 | -666 | 1,852 | -26% | -$185.1K | |
| D | 2026-02-13 | 2026-02-11 | LH | Oyegunwa Akinbolade | EVP, CIO, CTO | F - Tax | $289.89 | -68 | 4,106 | -2% | -$19.7K |
| D | 2026-02-13 | 2026-02-11 | LH | Oyegunwa Akinbolade | EVP, CIO, CTO | M - OptEx | — | +230 | 4,174 | +6% | — |
| D | 2026-02-13 | 2026-02-11 | LH | Vaughn Bryan T | EVP, Diagnostics | M - OptEx | — | +323 | 5,706 | +6% | — |
| D | 2026-02-13 | 2026-02-11 | LH | Vaughn Bryan T | EVP, Diagnostics | F - Tax | $289.89 | -93 | 5,613 | -2% | -$27.0K |
| D | 2026-02-13 | 2026-02-11 | LH | Wengel Kathryn E | Dir | M - OptEx | — | +897 | 4,133 | +28% | — |
| D | 2026-02-13 | 2026-02-11 | LH | Schechter Adam H | Pres, CEO, Dir | M - OptEx | — | +3,656 | 91.0K | +4% | — |
| D | 2026-02-13 | 2026-02-11 | LH | Schechter Adam H | Pres, CEO, Dir | F - Tax | $289.89 | -1,521 | 89.5K | -2% | -$440.9K |
| D | 2026-02-13 | 2026-02-11 | LH | Schechter Adam H | Pres, CEO, Dir | S - Sale+OE | $284.38 | -5,273 | 87.3K | -6% | -$1.50M |
| D | 2026-02-13 | 2026-02-11 | LH | NEUPERT PETER M | Dir | M - OptEx | — | +897 | 13.8K | +7% | — |
| D | 2026-02-13 | 2026-02-11 | LH | Bailey Megan D. | EVP, Pres, Central Labs, Intl | M - OptEx | — | +403 | 4,286 | +10% | — |
| D | 2026-02-13 | 2026-02-11 | LH | Bailey Megan D. | EVP, Pres, Central Labs, Intl | F - Tax | $289.89 | -138 | 4,148 | -3% | -$40.0K |
| D | 2026-02-13 | 2026-02-11 | LH | Parham Richelle P | Dir | M - OptEx | — | +897 | 3,366 | +36% | — |
| D | 2026-02-13 | 2026-02-11 | LH | Summy Amy B. | EVP, CMO | F - Tax | $289.89 | -83 | 5,722 | -1% | -$24.1K |
| D | 2026-02-13 | 2026-02-11 | LH | Summy Amy B. | EVP, CMO | M - OptEx | — | +230 | 5,804 | +4% | — |
| D | 2026-02-13 | 2026-02-11 | LH | Schroeder Mark S | EVP, COO, Pres Diagnostics | M - OptEx | — | +806 | 6,732 | +14% | — |
| D | 2026-02-13 | 2026-02-11 | LH | Schroeder Mark S | EVP, COO, Pres Diagnostics | F - Tax | $289.89 | -259 | 6,473 | -4% | -$75.1K |
| D | 2026-02-13 | 2026-02-11 | LH | GRAHAM ANITA Z | EVP, CHRO | M - OptEx | — | +356 | 1,569 | +29% | — |
| D | 2026-02-13 | 2026-02-11 | LH | GRAHAM ANITA Z | EVP, CHRO | F - Tax | $289.89 | -109 | 1,460 | -7% | -$31.6K |
| D | 2026-02-13 | 2026-02-11 | LH | ANDERSON KERRII B | Dir | M - OptEx | — | +897 | 9,563 | +10% | — |
| D | 2026-02-13 | 2026-02-11 | LH | Davis Jeffrey A. | Dir | M - OptEx | — | +897 | 5,460 | +20% | — |
| D | 2026-02-13 | 2026-02-11 | LH | Wang Julia Aijun | CFO, EVP | M - OptEx | — | +860 | 2,062 | +72% | — |
| D | 2026-02-13 | 2026-02-11 | LH | Wang Julia Aijun | CFO, EVP | F - Tax | $289.89 | -245 | 1,817 | -12% | -$71.0K |
| D | 2026-02-13 | 2026-02-11 | LH | Kliphouse Kirsten Marie | Dir | M - OptEx | — | +897 | 3,160 | +40% | — |
| D | 2026-02-13 | 2026-02-11 | LH | Kyle Kathryn W | EVP, CLO | M - OptEx | — | +216 | 3,504 | +7% | — |
| D | 2026-02-13 | 2026-02-11 | LH | Kyle Kathryn W | EVP, CLO | F - Tax | $289.89 | -62 | 3,442 | -2% | -$18.0K |
| D | 2026-02-13 | 2026-02-12 | LH | Meltzer Jonathan C | EVP, Ops | S - Sale+OE | $290.42 | -87 | 2,782 | -3% | -$25.3K |
| D | 2026-02-13 | 2026-02-11 | LH | Meltzer Jonathan C | EVP, Ops | F - Tax | $289.89 | -70 | 2,869 | -2% | -$20.3K |
| D | 2026-02-13 | 2026-02-11 | LH | Meltzer Jonathan C | EVP, Ops | M - OptEx | — | +243 | 2,939 | +9% | — |
| D | 2026-02-13 | 2026-02-11 | LH | Rothman Paul | Dir | M - OptEx | — | +897 | 2,571 | +54% | — |
| DM | 2026-02-13 | 2026-02-11 | LH | Wilkinson Peter J | SVP, CAO | F - Tax | $289.89 | -206 | 2,518 | -8% | -$59.7K |
| DM | 2026-02-13 | 2026-02-11 | LH | Wilkinson Peter J | SVP, CAO | M - OptEx | — | +696 | 2,564 | +37% | — |
| D | 2026-02-13 | 2026-02-11 | LH | van der Vaart Sandra D | EVP, Corp. Affairs | F - Tax | $289.89 | -99 | 3,126 | -3% | -$28.7K |
| D | 2026-02-13 | 2026-02-11 | LH | van der Vaart Sandra D | EVP, Corp. Affairs | M - OptEx | — | +376 | 3,225 | +13% | — |
| D | 2026-02-13 | 2026-02-11 | LH | Caveney Brian J | EVP, CMO, CSO, Pres of ED | M - OptEx | — | +740 | 31.8K | +2% | — |
| D | 2026-02-13 | 2026-02-11 | LH | Caveney Brian J | EVP, CMO, CSO, Pres of ED | F - Tax | $289.89 | -211 | 31.6K | -0.7% | -$61.2K |
| D | 2026-02-13 | 2026-02-11 | LH | Kong Garheng | Dir | M - OptEx | — | +897 | 13.7K | +7% | — |
| D | 2026-02-12 | 2026-02-10 | LH | Meltzer Jonathan C | EVP, Ops | S - Sale | $276.79 | -91 | 2,696 | -3% | -$25.2K |
| DM | 2026-02-10 | 2026-02-06+ | LH | Meltzer Jonathan C | EVP, Ops | F - Tax | $275.69 | -173 | 2,787 | -6% | -$47.7K |
| DM | 2026-02-10 | 2026-02-06+ | LH | Meltzer Jonathan C | EVP, Ops | M - OptEx | — | +530 | 2,785 | +23% | — |
| D | 2026-02-10 | 2026-02-09 | LH | Meltzer Jonathan C | EVP, Ops | S - Sale+OE | $275.53 | -88 | 2,869 | -3% | -$24.2K |
| DM | 2026-02-10 | 2026-02-06+ | LH | Caveney Brian J | EVP, CMO, CSO, Pres of ED | M - OptEx | — | +1,298 | 31.1K | +4% | — |
| DM | 2026-02-10 | 2026-02-06+ | LH | Caveney Brian J | EVP, CMO, CSO, Pres of ED | F - Tax | $275.72 | -389 | 31.1K | -1% | -$107.3K |
| DM | 2026-02-10 | 2026-02-06+ | LH | Oyegunwa Akinbolade | EVP, CIO, CTO | M - OptEx | — | +329 | 3,995 | +9% | — |
| DM | 2026-02-10 | 2026-02-06+ | LH | Oyegunwa Akinbolade | EVP, CIO, CTO | F - Tax | $275.75 | -112 | 3,846 | -3% | -$30.9K |
| DM | 2026-02-10 | 2026-02-06+ | LH | Wilkinson Peter J | SVP, CAO | M - OptEx | — | +267 | 2,074 | +15% | — |
| DM | 2026-02-10 | 2026-02-06+ | LH | Wilkinson Peter J | SVP, CAO | F - Tax | $275.59 | -91 | 1,940 | -4% | -$25.1K |
| DM | 2026-02-10 | 2026-02-06+ | LH | Schroeder Mark S | EVP, COO, Pres Diagnostics | M - OptEx | — | +1,424 | 6,145 | +30% | — |
| DM | 2026-02-10 | 2026-02-06+ | LH | Schroeder Mark S | EVP, COO, Pres Diagnostics | F - Tax | $275.67 | -458 | 5,926 | -7% | -$126.3K |
| D | 2026-02-10 | 2026-02-06 | LH | Wang Julia Aijun | CFO, EVP | F - Tax | $277.20 | -254 | 1,202 | -17% | -$70.4K |
| D | 2026-02-10 | 2026-02-06 | LH | Wang Julia Aijun | CFO, EVP | M - OptEx | — | +893 | 1,456 | +159% | — |
| DM | 2026-02-10 | 2026-02-06+ | LH | GRAHAM ANITA Z | EVP, CHRO | F - Tax | $275.65 | -231 | 958 | -19% | -$63.7K |
| DM | 2026-02-10 | 2026-02-06+ | LH | GRAHAM ANITA Z | EVP, CHRO | M - OptEx | — | +694 | 1,077 | +181% | — |
| DM | 2026-02-10 | 2026-02-06+ | LH | Bailey Megan D. | EVP, Pres, Central Labs, Intl | F - Tax | $275.29 | -180 | 3,702 | -5% | -$49.6K |
| DM | 2026-02-10 | 2026-02-06+ | LH | Bailey Megan D. | EVP, Pres, Central Labs, Intl | M - OptEx | — | +469 | 3,991 | +13% | — |
| DM | 2026-02-10 | 2026-02-06+ | LH | Vaughn Bryan T | EVP, Diagnostics | M - OptEx | — | +358 | 5,444 | +7% | — |
| DM | 2026-02-10 | 2026-02-06+ | LH | Vaughn Bryan T | EVP, Diagnostics | F - Tax | $275.60 | -122 | 5,383 | -2% | -$33.6K |
| DM | 2026-02-10 | 2026-02-06+ | LH | Kyle Kathryn W | EVP, CLO | M - OptEx | — | +358 | 3,349 | +12% | — |
Purchase Sale Sale after option exercise All abbreviations